Comparison of unadjusted and adjusted bone turnover markers between people living with and without HIV of both sexes.

Figshare2022-11-21 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Comparison_of_unadjusted_and_adjusted_bone_turnover_markers_between_people_living_with_and_without_HIV_of_both_sexes_/21595942 数据链接链接失效反馈

官方服务：

资源简介：

Comparison of unadjusted and adjusted bone turnover markers between people living with and without HIV of both sexes.

创建时间：

2022-11-21

ATN 109 Immunology Results Form, Version 2: Test Results [CRF 13] Dataset in Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Effectiveness of Vitamin D3 Supplement to Increase Bone Mineral Density and Decrease Tenofovir-Induced Hyperparathyroidism in HIV Positive Youth Treated with ART Containing Tenofovir

HIV骨代谢

药物副作用临床试验

Data from Immunology Results Form, Version 2: Test Results [CRF 13] Study Description A randomized, double-blind, placebo-controlled trial of directly observed vitamin D versus placebo every 4 weeks f

NIAID Data Ecosystem60

Bone turnover outcomes.

HIV骨代谢

生物标志物研究

*Characteristics are compared between HIV serostatus groups with Wilcoxon rank-sum test for CTx and osteocalcin. †Multivariable analysis adjusted for age, gender, race, BMI, smoking, past 30 day alcoh

NIAID Data Ecosystem50

ATN 109 Family Disease History [CRF 89] Dataset in Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Effectiveness of Vitamin D3 Supplement to Increase Bone Mineral Density and Decrease Tenofovir-Induced Hyperparathyroidism in HIV Positive Youth Treated with ART Containing Tenofovir

HIV骨代谢

维生素D3临床试验

Data from Family Disease History [CRF 89] Study Description A randomized, double-blind, placebo-controlled trial of directly observed vitamin D versus placebo every 4 weeks for 48 weeks. Participants

NIAID Data Ecosystem50

ATN 109 Immunology Results Form: Test Results [CRF 13] Dataset in Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Effectiveness of Vitamin D3 Supplement to Increase Bone Mineral Density and Decrease Tenofovir-Induced Hyperparathyroidism in HIV Positive Youth Treated with ART Containing Tenofovir

HIV骨代谢

维生素D3补充

Data from Immunology Results Form: Test Results [CRF 13] Study Description A randomized, double-blind, placebo-controlled trial of directly observed vitamin D versus placebo every 4 weeks for 48 weeks

NIAID Data Ecosystem60

ATN 109 Specimen Tracking Form, Version 3: Blood – Gray Top or Fluoride Tube [CRF 100V3] Dataset in Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Effectiveness of Vitamin D3 Supplement to Increase Bone Mineral Density and Decrease Tenofovir-Induced Hyperparathyroidism in HIV Positive Youth Treated with ART Containing Tenofovir

HIV骨代谢

抗逆转录病毒药物副作用

Data from Specimen Tracking Form, Version 3: Blood – Gray Top or Fluoride Tube [CRF 100V3] Study Description A randomized, double-blind, placebo-controlled trial of directly observed vitamin D versus

NIAID Data Ecosystem50

Comparison of unadjusted and adjusted bone turnover markers between people living with and without HIV of both sexes.

资源简介：

相关数据集